These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34190390)

  • 21. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.
    Wang WJ; Wu TY; Tu YK; Kuo KL; Tsai CY; Chie WC
    Indian J Dermatol Venereol Leprol; 2023; 89(2):189-194. PubMed ID: 36332095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
    Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
    Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study.
    Sharma P; Pai HS; Pai GS; Kuruvila M; Kolar R
    Am J Clin Dermatol; 2011 Apr; 12(2):127-32. PubMed ID: 21348543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Efficacy of Tranexamic Acid Solution 5% in the Treatment of Melasma in Patients of South Asian Descent.
    Akhtar N; Shah RR; Waqas N; Jasti S; Sharif S; Shah A; Abbasi HH; Rao B
    Cutis; 2023 Oct; 112(4):187-191.E4. PubMed ID: 37988305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis.
    Liang R; Luo H; Pan W; Yang S; Peng X; Kuang B; Huang H; Liu C
    J Cosmet Dermatol; 2024 Apr; 23(4):1150-1164. PubMed ID: 38059683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing practices of tranexamic acid for melasma: Delphi consensus from the Pigmentary Disorders Society.
    Sarkar R; Narayan R V; Vinay K; Lakhani R; Sinha S; Mysore V; Sendhil Kumaran M; Bhalla M; Das A; Swarnkar B; Mohan Thappa D; Podder I; Ojha Sharma R; Kumar Somani V; Barua S; Jagadeesan S; Dogra S
    Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):41-45. PubMed ID: 37609738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal application of tranexamic acid (TA) as treatment of melasma in the out-patients department of a public sector hospital: A pilot study.
    Mehmood M; Ali M; Saleem MA; Asghar S; Hussain MT; Mehmood A
    J Pak Med Assoc; 2022 Nov; 72(11):2275-2277. PubMed ID: 37013301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: A randomized, self-controlled, split-face study.
    Xu Y; Ma R; Juliandri J; Wang X; Xu B; Wang D; Lu Y; Zhou B; Luo D
    Medicine (Baltimore); 2017 May; 96(19):e6897. PubMed ID: 28489798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of mesotherapy with tranexamic acid versus vitamin C in the treatment of melasma: A meta-analysis and systemic review.
    Liao X; Cheng F; Jiang Y
    J Cosmet Dermatol; 2024 Sep; 23(9):2785-2792. PubMed ID: 38693699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.